DonorPlex™ Pooled Donor Human Hepatocytes Enable the Next Level of Reliability | Lonza

Posted by

Lonza

Watch our expert, Maureen Bunger, PhD, explain how our patented manufacturing process ensures that the DonorPlex™ Hepatocytes exhibit improved phenotype reproducibility. Additionally, we have a proprietary algorithm that predicts yield, viability and functional phenotype prior to manufacture which ensures individual customer specifications are met. Learn more about DonorPlex™ Pooled Donor Human Hepatocytes: https://bioscience.lonza.com/pooled-human-donor-hepatocytes Learn how Lonza can support your liver research applications: https://bioscience.lonza.com/liver-studies-for-adme-tox-studies DonorPlex™ Pooled Donor Human Hepatocytes products from Lonza: https://bioscience.lonza.com/search/?text=donorplex #ADME #Toxicology #Drugmetabolism #pharmacokinetic #DrugDiscovery #hepatocytes #primarycells #FDA #Lonza #DrugDrugInteraction #DDI